SYNVENTA, LLC
Etimizol, a respiratory stimulant molecule to reverse drug-induced respiratory depression from opioids and xylazine combinations
- Sector
- Biotech
- Total capital
- $500K
- Federal grants
- $500K
- 2 awards · 2019–2025
- Rank in peer group#263 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Etimizol for reversal of Xylazine-fentanyl respiratory depression$277K
- Federal grantHealth and Human S · Phase I · Fixed dose analgesic combination with non-opioid mechanism to prevent opioid misuse$222K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 4- PendingCompositions And Methods For Treatment Of PainUSPTOApplication 18204983
- PendingCompositions And Methods For Treatment Of PainUSPTOApplication 17100433
- PendingCompositions And Methods For Treatment Of PainUSPTOApplication PCTUS2020061615
Show all 4 patent records
- Compositions And Methods For Treatment Of PainNov 30, 2023 · Application 18204983Pending
- Compositions And Methods For Treatment Of PainMay 27, 2021 · Application 17100433Pending
- Compositions And Methods For Treatment Of PainApplication PCTUS2020061615Pending
- Compositions And Methods For Treatment Of PainApplication 62938697Pending
Related companies, and why
- Aincobio LLCSimilar federal contract value in Biotech · null in contracts
- GENMA BIOSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- OAK RIDGE THERAPEUTIC DISCOVERY (ORRXD), LLCSimilar federal contract value in Biotech · null in contracts
- MONOMERCHEM, incSimilar federal contract value in Biotech · null in contracts
- SPOTLIGHT THERAPEUTICSSimilar federal contract value in Biotech · null in contracts
- IMMUNEBRO THERAPEUTICS INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .